Evolution of the Cancer Stem Cell Model
Antonija Kreso,John E. Dick +1 more
2.1K
TL;DR: It is proposed that the genetic and CSC models of cancer can be harmonized by considering the role of genetic diversity and nongenetic influences in contributing to tumor heterogeneity.
read more
About: This article is published in Cell Stem Cell. The article was published on 06 Mar 2014. and is currently open access. The article focuses on the topics: Cancer stem cell & Cancer.
read more
Chat with Paper
AI Agents for this Paper
Find similar papers on Google Scholar, PubMed and Arxiv
Write a critical review of this paper
Analyze citations of this paper to find unaddressed research gaps
Citations
Exploring the promising potential of induced pluripotent stem cells in cancer research and therapy
Matin Chehelgerdi,Fereshteh Behdarvand Dehkordi,Mohammad Chehelgerdi,Hamidreza Kabiri,Hosein Salehian-Dehkordi,Mohammad Abdolvand,S H Salmanizadeh,Mohsen Rashidi,Anoosha Niazmand,Saba Ahmadi,Sara Feizbakhshan,Saber Kabiri,Nasimeh Vatandoost,Tayebeh Ranjbarnejad +13 more
TL;DR: An overview of the science behind iPSCs, the current limitations and challenges in iPSC-based cancer therapy, the ethical and social implications, and the comparative analysis with other stem cell types for cancer treatment are provided.
53
Targeting stem cells in the realm of drug-resistant breast cancer
Pranay Dey,Maitreyi Rathod,Abhijit De +2 more
- 07 Mar 2019
TL;DR: The intent is to discuss versatile therapeutics in practice followed by discussing the upcoming therapy strategies in the pipeline for BC, which focus on the roles played by BCSCs in mediating the resistance to cellular insults.
2-Indolinone a versatile scaffold for treatment of cancer: a patent review (2008–2014)
TL;DR: 2-indolinone has not exhausted all of its potential in the development of new compounds for clinical applications and remains a great tool for future research.
53
miR-99 regulates normal and malignant hematopoietic stem cell self-renewal.
Mona Khalaj,Mona Khalaj,Carolien M. Woolthuis,Wenhuo Hu,Benjamin H. Durham,S. Haihua Chu,Sarah Qamar,Sarah Qamar,Scott A. Armstrong,Christopher Y. Park +9 more
TL;DR: It is shown that miR-99 regulates self-renewal in both hematopoietic stem cells and acute myeloid leukemia stem cells (LSCs) compared with their differentiated progeny, and the importance of noncoding RNAs in the regulation of HSC and LSC function is demonstrated.
Leukemia-Initiating Cells in T-Cell Acute Lymphoblastic Leukemia.
TL;DR: Oncogenic transcription factors TAL1, LMO2, and NOTCH1 are focused on and the significance of the transcriptional regulatory programs in normal hematopoietic stem cells and T-ALL is highlighted.
References
Hallmarks of cancer: the next generation.
TL;DR: Recognition of the widespread applicability of these concepts will increasingly affect the development of new means to treat human cancer.
63.3K
Prospective identification of tumorigenic breast cancer cells
Muhammad Al-Hajj,Max S. Wicha,Adalberto Benito-Hernandez,Sean J. Morrison,Sean J. Morrison,Michael F. Clarke +5 more
TL;DR: The ability to prospectively identify tumorigenic cancer cells will facilitate the elucidation of pathways that regulate their growth and survival and strategies designed to target this population may lead to more effective therapies.
Signatures of mutational processes in human cancer
Ludmil B. Alexandrov,Serena Nik-Zainal,Serena Nik-Zainal,David C. Wedge,Samuel Aparicio,Sam Behjati,Sam Behjati,Andrew V. Biankin,Graham R. Bignell,Niccolo Bolli,Niccolo Bolli,Åke Borg,Anne Lise Børresen-Dale,Anne Lise Børresen-Dale,Sandrine Boyault,Birgit Burkhardt,Adam Butler,Carlos Caldas,Helen Davies,Christine Desmedt,Roland Eils,Jorunn E. Eyfjord,John A. Foekens,Mel Greaves,Fumie Hosoda,Barbara Hutter,Tomislav Ilicic,Sandrine Imbeaud,Sandrine Imbeaud,Marcin Imielinsk,Natalie Jäger,David T. W. Jones,David T. Jones,Stian Knappskog,Stian Knappskog,Marcel Kool,Sunil R. Lakhani,Carlos López-Otín,Sancha Martin,Nikhil C. Munshi,Nikhil C. Munshi,Hiromi Nakamura,Paul A. Northcott,Marina Pajic,Elli Papaemmanuil,Angelo Paradiso,John V. Pearson,Xose S. Puente,Keiran Raine,Manasa Ramakrishna,Andrea L. Richardson,Andrea L. Richardson,Julia Richter,Philip Rosenstiel,Matthias Schlesner,Ton N. Schumacher,Paul N. Span,Jon W. Teague,Yasushi Totoki,Andrew Tutt,Rafael Valdés-Mas,Marit M. van Buuren,Laura van ’t Veer,Anne Vincent-Salomon,Nicola Waddell,Lucy R. Yates,Icgc PedBrain,Jessica Zucman-Rossi,Jessica Zucman-Rossi,P. Andrew Futreal,Ultan McDermott,Peter Lichter,Matthew Meyerson,Matthew Meyerson,Sean M. Grimmond,Reiner Siebert,Elias Campo,Tatsuhiro Shibata,Stefan M. Pfister,Stefan M. Pfister,Peter J. Campbell,Peter J. Campbell,Peter J. Campbell,Michael R. Stratton,Michael R. Stratton +84 more
TL;DR: It is shown that hypermutation localized to small genomic regions, ‘kataegis’, is found in many cancer types, and this results reveal the diversity of mutational processes underlying the development of cancer.
The Epithelial-Mesenchymal Transition Generates Cells with Properties of Stem Cells
Sendurai A. Mani,Wenjun Guo,Mai Jing Liao,Elinor Ng Eaton,Ayyakkannu Ayyanan,Alicia Y. Zhou,Mary W. Brooks,Ferenc Reinhard,Cheng Cheng Zhang,Michail Shipitsin,Lauren L. Campbell,Kornelia Polyak,Cathrin Brisken,Jing Yang,Robert A. Weinberg +14 more
TL;DR: It is reported that the induction of an EMT in immortalized human mammary epithelial cells (HMLEs) results in the acquisition of mesenchymal traits and in the expression of stem-cell markers, and it is shown that those cells have an increased ability to form mammospheres, a property associated with mammARY epithelial stem cells.
9K